Additional Resources Learn more about microdosing GLP-1s with Dr
The volume of solvent you choose determines the final concentration of your solution
GLP-1s may additionally impact other physiological changes observed in the perimenopausal period, including vasomotor symptoms like hot flashes and night sweats, declines in bone health, and unhealthy changes in body composition (gains in fat mass and declines in muscle mass), but whether these impacts are beneficial or harmful for women's health remains unknown
My decade of experience in holistic health has taught me that understanding your options is key to making informed decisions about elective IV therapy
Data are still accumulating and no definitive answer has emerged [211,212]
No, the MHRA does not licence HCG for weight management, and NICE does not recommend it